Products & Services · Transaction price

License — Transaction price

Alnylam Pharmaceuticals License — Transaction price remained flat by 0.0% to $1.74B in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment
First reportedQ3 2025
Last reportedQ1 2026
Metric ID: alny_segment_license_transaction_price

Historical Data

3 periods
 Q3 '25Q4 '25Q1 '26
Value$1.74B$1.74B$1.74B
QoQ Change—+0.0%+0.0%
Range$1.74B – $1.74B
Current Streak2+ quarters growth

Frequently Asked Questions

What is Alnylam Pharmaceuticals's license — transaction price?
Alnylam Pharmaceuticals (ALNY) reported license — transaction price of $1.74B in Q1 2026.